FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

FusionGeneSummary

leaf

FusionProtFeature

leaf

FusionGeneSequence

leaf

FusionGenePPI

leaf

RelatedDrugs

leaf

RelatedDiseases

Fusion gene ID: 21978

FusionGeneSummary for MINPP1_ASXL2

check button Fusion gene summary
Fusion gene informationFusion gene name: MINPP1_ASXL2
Fusion gene ID: 21978
HgeneTgene
Gene symbol

MINPP1

ASXL2

Gene ID

9562

55252

Gene namemultiple inositol-polyphosphate phosphatase 1ASXL transcriptional regulator 2
SynonymsHIPER1|MINPP2|MIPPASXH2|SHAPNS
Cytomap

10q23.2

2p23.3

Type of geneprotein-codingprotein-coding
Descriptionmultiple inositol polyphosphate phosphatase 12,3-BPG phosphatase2,3-bisphosphoglycerate 3-phosphataseinositol (1,3,4,5)-tetrakisphosphate 3-phosphataseins(1,3,4,5)P(4) 3-phosphatasemultiple inositol polyphosphate histidine phosphatase, 1multiple inoputative Polycomb group protein ASXL2additional sex combs like 2, transcriptional regulatoradditional sex combs-like protein 2polycomb group protein ASXH2
Modification date2018052320180523
UniProtAcc

Q9UNW1

Q76L83

Ensembl transtripts involved in fusion geneENST00000371996, ENST00000371994, 
ENST00000536010, ENST00000472891, 
ENST00000435504, ENST00000336112, 
ENST00000272341, ENST00000404843, 
ENST00000497092, 
Fusion gene scores* DoF score3 X 3 X 3=277 X 10 X 5=350
# samples 310
** MAII scorelog2(3/27*10)=0.15200309344505
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
log2(10/350*10)=-1.8073549220576
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: MINPP1 [Title/Abstract] AND ASXL2 [Title/Abstract] AND fusion [Title/Abstract]

Functional or gene categories assigned by FusionGDB annotation
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneASXL2

GO:0035360

positive regulation of peroxisome proliferator activated receptor signaling pathway

21047783

TgeneASXL2

GO:0045600

positive regulation of fat cell differentiation

21047783

TgeneASXL2

GO:0045944

positive regulation of transcription by RNA polymerase II

21047783


check button Fusion gene information from three resources
(ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018))
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
Data typeSourceCancer typeSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
TCGARVLUSCTCGA-90-7769-01AMINPP1chr10

89268290

+ASXL2chr2

26068432

-
* LD: Li Ding group's fusion gene list
  RV: Roel Verhaak group's fusion gene list
  ChiTaRs fusion database

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
Frame-shiftENST00000371996ENST00000435504MINPP1chr10

89268290

+ASXL2chr2

26068432

-
5CDS-5UTRENST00000371996ENST00000336112MINPP1chr10

89268290

+ASXL2chr2

26068432

-
5CDS-5UTRENST00000371996ENST00000272341MINPP1chr10

89268290

+ASXL2chr2

26068432

-
5CDS-intronENST00000371996ENST00000404843MINPP1chr10

89268290

+ASXL2chr2

26068432

-
5CDS-intronENST00000371996ENST00000497092MINPP1chr10

89268290

+ASXL2chr2

26068432

-
Frame-shiftENST00000371994ENST00000435504MINPP1chr10

89268290

+ASXL2chr2

26068432

-
5CDS-5UTRENST00000371994ENST00000336112MINPP1chr10

89268290

+ASXL2chr2

26068432

-
5CDS-5UTRENST00000371994ENST00000272341MINPP1chr10

89268290

+ASXL2chr2

26068432

-
5CDS-intronENST00000371994ENST00000404843MINPP1chr10

89268290

+ASXL2chr2

26068432

-
5CDS-intronENST00000371994ENST00000497092MINPP1chr10

89268290

+ASXL2chr2

26068432

-
Frame-shiftENST00000536010ENST00000435504MINPP1chr10

89268290

+ASXL2chr2

26068432

-
5CDS-5UTRENST00000536010ENST00000336112MINPP1chr10

89268290

+ASXL2chr2

26068432

-
5CDS-5UTRENST00000536010ENST00000272341MINPP1chr10

89268290

+ASXL2chr2

26068432

-
5CDS-intronENST00000536010ENST00000404843MINPP1chr10

89268290

+ASXL2chr2

26068432

-
5CDS-intronENST00000536010ENST00000497092MINPP1chr10

89268290

+ASXL2chr2

26068432

-
intron-3CDSENST00000472891ENST00000435504MINPP1chr10

89268290

+ASXL2chr2

26068432

-
intron-5UTRENST00000472891ENST00000336112MINPP1chr10

89268290

+ASXL2chr2

26068432

-
intron-5UTRENST00000472891ENST00000272341MINPP1chr10

89268290

+ASXL2chr2

26068432

-
intron-intronENST00000472891ENST00000404843MINPP1chr10

89268290

+ASXL2chr2

26068432

-
intron-intronENST00000472891ENST00000497092MINPP1chr10

89268290

+ASXL2chr2

26068432

-

Top

FusionProtFeatures for MINPP1_ASXL2


check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
MINPP1

Q9UNW1

ASXL2

Q76L83

Acts as a phosphoinositide 5- and phosphoinositide 6-phosphatase and regulates cellular levels of inositolpentakisphosphate (InsP5) and inositol hexakisphosphate (InsP6).Also acts as a 2,3-bisphosphoglycerate 3-phosphatase, by mediatingthe dephosphorylation of 2,3-bisphosphoglycerate (2,3-BPG) toproduce phospho-D-glycerate without formation of 3-phosphoglycerate. May play a role in bone development(endochondral ossification). May play a role in the transition ofchondrocytes from proliferation to hypertrophy (By similarity).{ECO:0000250|UniProtKB:F1NPQ2, ECO:0000269|PubMed:18413611}. Putative Polycomb group (PcG) protein. PcG proteins actby forming multiprotein complexes, which are required to maintainthe transcriptionally repressive state of homeotic genesthroughout development. PcG proteins are not required to initiaterepression, but to maintain it during later stages of development.They probably act via methylation of histones, rendering chromatinheritably changed in its expressibility (By similarity). Involvedin transcriptional regulation mediated by ligand-bound nuclearhormone receptors, such as peroxisome proliferator-activatedreceptor gamma (PPARG). Acts as coactivator for PPARG and enhancesits adipocyte differentiation-inducing activity; the functionseems to involve differential recruitment of acetylated andmethylated histone H3. {ECO:0000250, ECO:0000269|PubMed:21047783}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page

.

* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

FusionGeneSequence for MINPP1_ASXL2


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences.
(nt: nucleotides, aa: amino acids)

* Fusion amino acid sequences.

* Fusion transcript sequences (only coding sequence (CDS) region).

* Fusion transcript sequences (Full-length transcript).

Top

FusionGenePPI for MINPP1_ASXL2


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page

.

check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors
MINPP1CD274, FBXO6, CYP1A1, LYPD6, TMCO6, SOX4, PPP5C, TCTN1, VWA1, C1orf87, HNRNPLL, MRS2, SPINK4, GDAP1, GIMAP1, FOXRED1ASXL2TRAF6, BAP1, APP, PRPF40A, HECW2, KDM1B, MBD6, FOXK1, MBD5, EXOSC2, KRBOX4, FOXK2, OGT, HCFC1, UBC, TRIM25


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

RelatedDrugs for MINPP1_ASXL2


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.0 2018-04-02)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

RelatedDiseases for MINPP1_ASXL2


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneMINPP1C0037274Dermatologic disorders1CTD_human
HgeneMINPP1C0311375Arsenic Poisoning1CTD_human
HgeneMINPP1C4225426THYROID CANCER, NONMEDULLARY, 21UNIPROT
TgeneASXL2C0005695Bladder Neoplasm1CTD_human
TgeneASXL2C0023467Leukemia, Myelocytic, Acute1CTD_human